Literature DB >> 17563535

Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME Study.

Teemu Niiranen1, Antti Jula, Ilkka Kantola, Leena Moilanen, Mika Kähönen, Y Antero Kesäniemi, Markku S Nieminen, Antti Reunanen.   

Abstract

BACKGROUND: The aim of this study was to assess whether carotid intima-media thickness (IMT) is more strongly associated with home-measured blood pressure (BP) than clinic BP. Other risk factors associated with carotid atherosclerosis were also investigated.
METHODS: We studied a representative unselected sample of the Finnish adult population (758 subjects aged 45-74 years). Subjects included in the study underwent a clinical interview, carotid ultrasonography, and measurement of clinic BP (mean of two measurements using a mercury sphygmomanometer) and home BP (mean of 14 duplicate measurements during 1 week using a validated, automatic device). Fasting blood samples for serum lipids and glucose were drawn.
RESULTS: The Pearson correlation coefficients for carotid IMT and home/clinic BP differed significantly in favour of home measurement for systolic BP (0.34 versus 0.25, P < 0.001), diastolic BP (0.20 versus 0.07, P < 0.001) and pulse pressure (0.37 versus 0.27, P < 0.001). In a linear regression model (R = 0.32, P < 0.001), age (P < 0.001), home systolic BP (P = 0.002), serum triglycerides (P = 0.006), male sex (P = 0.009), smoking (P = 0.017), diabetes (P = 0.035), and low-density lipoprotein cholesterol (P = 0.041) were independently associated with increased IMT. The association between home BP and carotid IMT did not increase with the number of home measurements.
CONCLUSION: BP is one of the most important factors in the pathogenesis of atherosclerosis. Home-measured BP is more strongly associated with carotid atherosclerosis than clinic BP, even for a low number of measurements. These data support the application of home BP measurement in clinical practice.

Entities:  

Mesh:

Year:  2007        PMID: 17563535     DOI: 10.1097/HJH.0b013e3280d94336

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Factors affecting variability in home blood pressure in patients with type 2 diabetes: post hoc analysis of a cross-sectional multicenter study.

Authors:  E Ushigome; M Fukui; M Hamaguchi; T Tanaka; H Atsuta; S-i Mogami; Y Oda; M Yamazaki; G Hasegawa; N Nakamura
Journal:  J Hum Hypertens       Date:  2014-02-06       Impact factor: 3.012

2.  Effect of intensive multifactorial treatment on the intima-media thickness of large arteries in patients with new-onset type 2 diabetes mellitus.

Authors:  Xiao-hong Zhao; Zhe-rong Xu; Qin Zhang; Hai-feng Gu; Yun-mei Yang
Journal:  J Zhejiang Univ Sci B       Date:  2012-05       Impact factor: 3.066

3.  The International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO): moving from baseline characteristics to research perspectives.

Authors:  Teemu J Niiranen; Lutgarde Thijs; Kei Asayama; Jouni K Johansson; Takayoshi Ohkubo; Masahiro Kikuya; José Boggia; Atsushi Hozawa; Edgardo Sandoya; George S Stergiou; Ichiro Tsuji; Antti M Jula; Yutaka Imai; Jan A Staessen
Journal:  Hypertens Res       Date:  2012-07-05       Impact factor: 3.872

4.  Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey.

Authors:  J Jylhävä; A Haarala; M Kähönen; T Lehtimäki; A Jula; L Moilanen; Y A Kesäniemi; M S Nieminen; M Hurme
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

5.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

6.  Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study.

Authors:  Takuro Okamura; Emi Ushigome; Nobuko Kitagawa; Chikako Oyabu; Toru Tanaka; Goji Hasegawa; Naoto Nakamura; Masayoshi Ohnishi; Sei Tsunoda; Hidetaka Ushigome; Isao Yokota; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Diabetes Investig       Date:  2019-05-07       Impact factor: 4.232

Review 7.  Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum.

Authors:  Sang-Hyun Ihm; Jae-Hyeong Park; Jang Young Kim; Ju-Han Kim; Kwang-Il Kim; Eun Mi Lee; Hae-Young Lee; Sungha Park; Jinho Shin; Cheol-Ho Kim
Journal:  Clin Hypertens       Date:  2022-10-01

8.  Masked hypertension defined by home blood pressure monitoring is associated with impaired flow-mediated vasodilatation in patients with cardiovascular risk factors.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-25       Impact factor: 3.738

Review 9.  Clinical applications for out-of-office blood pressure monitoring.

Authors:  Hailan Zhu; Haoxiao Zheng; Xinyue Liu; Weiyi Mai; Yuli Huang
Journal:  Ther Adv Chronic Dis       Date:  2020-01-20       Impact factor: 5.091

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.